Sectors

PRCT
PROCEPT BioRobotics Corporation
21.20
2 x 13.90
2 x 22.04
bid
ask
+
0.37
1.78%
2 @ 05:39 PM
21.00 -0.20 (0.94%)
Ytd-32.61%
1y-47.22%
20.38
day range
21.26
16.66
52 week range
42.43
Open20.76Prev Close20.83Low20.38High21.26Mkt Cap1.21B
Vol939.84KAvg Vol1.58MEPS-1.95P/EN/AForward P/E-18.39
Beta0.89Short Ratio4.22Inst. Own100.47%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning11-0450-d Avg20.33200-d Avg26.221yr Est21.64
Earning
DateForEstimateReportedSurprisesurprise %
2026-11-032026-09-0.39N/AN/AN/A
2026-08-042026-06-0.46-0.47-0.01-1.76%
2026-04-292026-03-0.55-0.56-0.01-1.82%
2026-02-252025-12-0.32-0.53-0.21-65.62%
2025-11-042025-09-0.41-0.380.037.32%
2025-08-062025-06-0.41-0.350.0614.63%
Upgrade / Downgrade
DateFirmActionFromTo
2026-08-05TD CowenUpgradeBuyBuy
2026-08-05Piper SandlerUpgradeOverweightOverweight
2026-08-05Evercore ISI GroupUpgradeOutperformOutperform
2026-08-05William BlairDowngradeOutperformMarket Perform
2026-07-06Truist SecuritiesDowngradeBuyHold
2026-06-24Evercore ISI GroupUpgradeOutperform
Profile
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology in the United States and internationally. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia. The company also provides HYDROS Robotic System, which provides Aquablation therapy image-guided robotic therapy to treat males suffering from lower urinary tract symptoms due to benign prostatic hyperplasia. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.
Insider Holder
DateNameRelationQuantityDescription
2026-06-08DESAI ANTAL ROHITDirector38.47KStock Award(Grant)
2026-06-08HARRIS TAYLOR CDirector102.49KStock Award(Grant)
2026-06-08MOLL FREDERIC HDirector866.47KStock Award(Grant)
2026-08-12NOURI ALALEHOfficer128.03KStock Award(Grant)
2026-08-12SHARMA POOJAOfficer111.18KStock Award(Grant)
2025-06-05SHIBLAQ HISHAMOfficer63.13KConversion of Exercise of derivative security
Institution Ownership
Report DateOrganizationPositionValuePercentage
2026-06-29Blackrock Inc.4.87M103.24M8.50%
2026-06-29T. Rowe Price Investment Management, Inc.3.27M69.23M5.70%
2026-06-29BNP Paribas Asset Management Holding S.A.2.82M59.87M4.93%
2026-06-29Vanguard Portfolio Management LLC2.53M53.57M4.41%
2026-06-29Vanguard Capital Management LLC2.46M52.17M4.30%
2026-06-29Chicago Capital, LLC2.07M43.95M3.62%
Fund Ownership
Report DateOrganizationPositionValuePercentage
2026-03-30VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund1.68M35.62M2.93%
2026-06-29iShares Trust-iShares Russell 2000 ETF1.46M30.92M2.55%
2026-03-30T. Rowe Price Small-Cap Stock Fund, Inc.1.32M27.97M2.30%
2026-03-30VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund1.24M26.19M2.16%
2026-06-29JANUS INVESTMENT FUND-Janus Henderson Venture Fund890.51K18.88M1.55%
2026-03-30T. Rowe Price Eqy. Fd.s, Inc.-T. Rowe Price Inst. Small-Cap Stock Fd.695.94K14.75M1.22%